XEOMIN
LIVE

Serial Number

79371939

Owner

Merz Pharma GmbH & Co. KGaA

Attorney

Jeff Van Hoosear

Filing Date

Feb 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

XEOMIN Trademark

Serial Number: 79371939 • Registration: 7504720

XEOMIN is a trademark filed by Merz Pharma GmbH & Co. KGaA on February 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstr. 100
Frankfurt am Main 60318 , DE

Entity Type: 23

Trademark Details

Filing Date

February 22, 2023

Registration Date

September 17, 2024

Published for Opposition

June 25, 2024

Goods & Services

Pharmaceutical products for use in dermatology in the aesthetic field; pharmaceutical products for relaxing muscles; pharmaceutical products for the treatment of wrinkles and facial fines and for the treatment of cerebral and neurological disorders, diseases and conditions; medical products for use in dermatology in the aesthetic field, namely, medicated dermatological preparations and substances; medical products for relaxing muscles, namely, muscle relaxants; medical products in the nature of botulinum toxin for the treatment of wrinkles and facial lines and the treatment of cerebral and neurological disorders, disease and conditions; medicaments for human medical use for the treatment of cerebral and neurological disorders, diseases and conditions; prefilled syringes sold filled with botulinum toxin for medical and pharmaceutical use in dermatology in the aesthetic field, for relaxing muscles, for the treatment of wrinkles and facial lines and for the treatment of cerebral and neurological disorders, diseases and conditions

Medical apparatus and instruments for medical use in dermatological procedures; hypodermic needles; hypodermic needles for injections; syringes for medical purposes; systems for injections consisting of hypodermic needles for injections; syringes for medical purposes and injection devices for pharmaceuticals in the nature of botulinum toxin; injection equipment for single doses, namely, needles for injections; containers for the administration of medicines, namely, containers for botulinum toxin

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 2, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 1, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 3, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 15, 2023 REPR